FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2173724387> ?p ?o ?g. }

• W2173724387 endingPage "334" @default.
• W2173724387 startingPage "326" @default.
• W2173724387 abstract "Statins have been reported to induce tendinopathy and even tendon rupture. The present study was designed to investigate the potential molecular mechanism underlying the adverse effect of simvastatin on tendon cells. An in vitro tendon healing model was performed using tendon cells isolated from rat Achilles tendons. The viability of tendon cells and cell cycle progression were examined by the MTT assay and flow cytometric analysis, respectively. Immunofluorescent staining for Ki-67 was used to assess the proliferation activity of tendon cells. Western blot analysis and coimmunoprecipitation was used to determine the protein expression of cell cycle-related proteins. To investigate the potential mechanism underlying the effect of statins on tendon cells, mevalonate, farnesyl pyrophosphate (FPP), or geranylgeranyl pyrophosphate (GGPP) was added to simvastatin-treated tendon cells. Simvastatin inhibited the in vitro tendon healing model and tendon cell proliferation in a dose-dependent manner. Immunofluorescent staining demonstrated reduced ki-67 expression in simvastatin-treated tendon cells. Furthermore, simvastatin induced cell cycle arrest at the G1 phase. The expression levels of cdk1, cdk2, cyclin A, and cyclin E were downregulated by simvastatin in a dose-dependent manner. The inhibitory effect of simvastatin was proved to mediate the reduction of mevalonate, and the addition of exogenous GGPP completely prevented the inhibitory effect of simvastatin on tendon cells. The present study demonstrated, for the first time, the molecular mechanism underlying simvastatin-induced tendinopathy or tendon rupture. GGPP was shown to prevent the adverse effect of simvastatin in tendon cells without interfering with its cholesterol-reducing efficacy." @default.
• W2173724387 created "2016-06-24" @default.
• W2173724387 creator A5010109073 @default.
• W2173724387 creator A5011358634 @default.
• W2173724387 creator A5032551978 @default.
• W2173724387 creator A5034965904 @default.
• W2173724387 creator A5053469074 @default.
• W2173724387 creator A5080345807 @default.
• W2173724387 date "2015-11-16" @default.
• W2173724387 modified "2023-10-17" @default.
• W2173724387 title "Prevention of Simvastatin-Induced Inhibition of Tendon Cell Proliferation and Cell Cycle Progression by Geranylgeranyl Pyrophosphate" @default.
• W2173724387 cites W1548752966 @default.
• W2173724387 cites W1594190685 @default.
• W2173724387 cites W1981206580 @default.
• W2173724387 cites W1982502126 @default.
• W2173724387 cites W1988201281 @default.
• W2173724387 cites W1995339205 @default.
• W2173724387 cites W2014944254 @default.
• W2173724387 cites W2015446431 @default.
• W2173724387 cites W2017168096 @default.
• W2173724387 cites W2042138802 @default.
• W2173724387 cites W2052548291 @default.
• W2173724387 cites W2084969952 @default.
• W2173724387 cites W2089414651 @default.
• W2173724387 cites W2094639271 @default.
• W2173724387 cites W2126708809 @default.
• W2173724387 cites W2127095041 @default.
• W2173724387 cites W2136772857 @default.
• W2173724387 cites W2141570734 @default.
• W2173724387 cites W47046980 @default.
• W2173724387 doi "https://doi.org/10.1093/toxsci/kfv239" @default.
• W2173724387 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26577051" @default.
• W2173724387 hasPublicationYear "2015" @default.
• W2173724387 type Work @default.
• W2173724387 sameAs 2173724387 @default.
• W2173724387 citedByCount "15" @default.
• W2173724387 countsByYear W21737243872017 @default.
• W2173724387 countsByYear W21737243872018 @default.
• W2173724387 countsByYear W21737243872019 @default.
• W2173724387 countsByYear W21737243872020 @default.
• W2173724387 countsByYear W21737243872022 @default.
• W2173724387 countsByYear W21737243872023 @default.
• W2173724387 crossrefType "journal-article" @default.
• W2173724387 hasAuthorship W2173724387A5010109073 @default.
• W2173724387 hasAuthorship W2173724387A5011358634 @default.
• W2173724387 hasAuthorship W2173724387A5032551978 @default.
• W2173724387 hasAuthorship W2173724387A5034965904 @default.
• W2173724387 hasAuthorship W2173724387A5053469074 @default.
• W2173724387 hasAuthorship W2173724387A5080345807 @default.
• W2173724387 hasBestOaLocation W21737243871 @default.
• W2173724387 hasConcept C134651460 @default.
• W2173724387 hasConcept C142724271 @default.
• W2173724387 hasConcept C1491633281 @default.
• W2173724387 hasConcept C181199279 @default.
• W2173724387 hasConcept C185592680 @default.
• W2173724387 hasConcept C199835354 @default.
• W2173724387 hasConcept C2776329913 @default.
• W2173724387 hasConcept C2776990775 @default.
• W2173724387 hasConcept C2778827360 @default.
• W2173724387 hasConcept C2779982574 @default.
• W2173724387 hasConcept C2780105995 @default.
• W2173724387 hasConcept C2780984734 @default.
• W2173724387 hasConcept C29537977 @default.
• W2173724387 hasConcept C502942594 @default.
• W2173724387 hasConcept C553450214 @default.
• W2173724387 hasConcept C55493867 @default.
• W2173724387 hasConcept C62112901 @default.
• W2173724387 hasConcept C71924100 @default.
• W2173724387 hasConcept C86803240 @default.
• W2173724387 hasConcept C95444343 @default.
• W2173724387 hasConcept C98274493 @default.
• W2173724387 hasConceptScore W2173724387C134651460 @default.
• W2173724387 hasConceptScore W2173724387C142724271 @default.
• W2173724387 hasConceptScore W2173724387C1491633281 @default.
• W2173724387 hasConceptScore W2173724387C181199279 @default.
• W2173724387 hasConceptScore W2173724387C185592680 @default.
• W2173724387 hasConceptScore W2173724387C199835354 @default.
• W2173724387 hasConceptScore W2173724387C2776329913 @default.
• W2173724387 hasConceptScore W2173724387C2776990775 @default.
• W2173724387 hasConceptScore W2173724387C2778827360 @default.
• W2173724387 hasConceptScore W2173724387C2779982574 @default.
• W2173724387 hasConceptScore W2173724387C2780105995 @default.
• W2173724387 hasConceptScore W2173724387C2780984734 @default.
• W2173724387 hasConceptScore W2173724387C29537977 @default.
• W2173724387 hasConceptScore W2173724387C502942594 @default.
• W2173724387 hasConceptScore W2173724387C553450214 @default.
• W2173724387 hasConceptScore W2173724387C55493867 @default.
• W2173724387 hasConceptScore W2173724387C62112901 @default.
• W2173724387 hasConceptScore W2173724387C71924100 @default.
• W2173724387 hasConceptScore W2173724387C86803240 @default.
• W2173724387 hasConceptScore W2173724387C95444343 @default.
• W2173724387 hasConceptScore W2173724387C98274493 @default.
• W2173724387 hasIssue "2" @default.
• W2173724387 hasLocation W21737243871 @default.
• W2173724387 hasLocation W21737243872 @default.
• W2173724387 hasOpenAccess W2173724387 @default.
• W2173724387 hasPrimaryLocation W21737243871 @default.
• W2173724387 hasRelatedWork W1796829301 @default.

• next